Navigation Links
Actavis Full Year 2012 Net Revenue Increases 29% to $5.91 Billion
Date:2/19/2013

ursement of pharmaceutical products and the settlement of patent litigation; and such other risks and uncertainties detailed in Actavis' periodic public filings with the Securities and Exchange Commission, including but not limited to Actavis' Annual Report on form 10-K for the year ended December 31, 2011 and its Quarterly Report on Form 10-Q for the period ended September 30, 2012 (such periodic public filings having been filed under the "Watson Pharmaceuticals, Inc." name).  Except as expressly required by law, Actavis disclaims any intent or obligation to update these forward-looking statements.

Trademarks noted in this press release are the property of their respective registered owners. CONTACTS: Investors:Lisa DeFrancesco (862) 261-7152Media:Charlie Mayr(862) 261-8030The following table presents Actavis' results of operations for the three and twelve months ended December 31, 2012 and 2011:Table 1Actavis, Inc.Condensed Consolidated Statement of Operations(Unaudited; in millions, except per share amounts)Three Months EndedTwelve Months EndedDecember 31,December 31,2012201120122011Net revenues$
,750.2$
,544.6$
5,914.9$
4,584.4Operating expenses:Cost of sales (excludes amortization, presented below)1,008.0892.73,390.42,564.9Research and development121.167.2401.8295.4Selling, general and administrative424.3213.01,171.3754.9Amortization148.2151.3481.1354.3Loss on asset sales and impairments, net29.953.1149.578.7Total operating expenses1,731.51,377.35,594.14,048.2Operating income 18.7167.3320.8536.2Non-operating income (expense):Interest income1.20.52.52.1Interest expense(54.6)(12.7)(116.7)(81.8)Other income (expense), net151.90.638.5(0.5)Total other income (expense), net98.5(11.6)(75.7)(80.2)Income before income taxes and noncontrolling interest 117.2155.7245.1456.0Provision for income taxes88.261.5146.8196.9Net income29.094.298.3259.1Loss attributable to noncontrolling interest(1.0)0.6(1.0)1.8Net income attributable to common sh
'/>"/>

SOURCE Actavis, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

Related medicine technology :

1. Watson to Acquire Actavis Group for EUR4.25 Billion
2. Actavis Launches First Generic Equivalent of Requip® XL (Ropinirole Extended-Release Tablets)
3. Actavis Launches Generic Equivalent of Adalat® CC 90mg (Nifedipine Extended-Release Tablets, USP)
4. Watson and Actavis Receive FTC Second Request
5. Watson Announces New Name -- Actavis -- for Global Operations
6. Watson Pharmaceuticals, Inc. is Now Actavis, Inc.
7. Actavis, Inc. to Host Fourth Quarter 2012 Earnings Conference Call and Webcast
8. Actavis, Inc. to Present at the RBC Capital Markets Healthcare Conference
9. Kelyniam Global Inc. Reports Record Cranial Implant Revenues in the 1st Quarter of 2012
10. CryoLife Reports Record Quarterly Revenues in First Quarter of 2012
11. Aethlon Medical Note: Fiscal Year Revenue Guidance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... YORK , July 30, 2015 /PRNewswire/ ... a new research report with market overview, ... share, forecast, porter analysis, recent developments, competitive ... Global Industry Insight: Biosensors Market Development ...      (Logo: http://photos.prnewswire.com/prnh/20150727/756778 ) ...
(Date:7/30/2015)... Global ENT (Ear, Nose, ... USD 23.01 million in 2022, according to a new ... geriatric population, increasing prevalence of ear, nose, and throat ... among target customer base are expected serve this market ... According to estimates published by the WHO, 15% of ...
(Date:7/30/2015)... Company, Inc. (NYSE: LCI ) today announced that ... Annual Growth Conference on Wednesday, August 12, 2015, at ... A webcast of the presentation will be ... visit the web site at least 10 minutes prior ... and install any necessary software.  The presentation will be ...
Breaking Medicine Technology:Global Biosensors Market (Size of $12,964 Million in 2014) to Witness 10% CAGR During 2015 - 2020 2Global Biosensors Market (Size of $12,964 Million in 2014) to Witness 10% CAGR During 2015 - 2020 3Global Biosensors Market (Size of $12,964 Million in 2014) to Witness 10% CAGR During 2015 - 2020 4Global Biosensors Market (Size of $12,964 Million in 2014) to Witness 10% CAGR During 2015 - 2020 5ENT Devices Market Size to Reach $23.01 Billion by 2022: Grand View Research, Inc. 2ENT Devices Market Size to Reach $23.01 Billion by 2022: Grand View Research, Inc. 3ENT Devices Market Size to Reach $23.01 Billion by 2022: Grand View Research, Inc. 4ENT Devices Market Size to Reach $23.01 Billion by 2022: Grand View Research, Inc. 5
(Date:7/30/2015)... ... July 30, 2015 , ... 24/7 Care At Home, ... San Bernardino counties, today announced that Dr. Michael Demoratz, PhD, LCSW, CCM is ... a strong proponent of early access to palliative care services for the underserved ...
(Date:7/30/2015)... ... July 30, 2015 , ... ... fourth annual Institute Scholar Program. In partnership with Patient Experience Institute, these offerings ... develop leaders on the front lines and throughout the experience movement, and provide ...
(Date:7/30/2015)... VA (PRWEB) , ... July 30, 2015 , ... ... introduction of the ‘Mary Jo Lawyer-Spano Mesothelioma Patient Registry Act of 2015’. ... Schakowsky (D-IL), Chris Collins (R-NY), Peter King (R-NY), Betty McCollum (D-MN), Joe Kennedy ...
(Date:7/30/2015)... ... July 30, 2015 , ... Boston Web Marketing ... All-Stars Summit. Google Partners is the platform for search marketing agencies to communicate ... and tools necessary to run successful search marketing campaigns. Google Partners also affords ...
(Date:7/30/2015)... ... July 30, 2015 , ... Ocean Hills Recovery has ... the very rare “no recommendations.” No recommendations means CARF found no areas in the ... notation that less than 3% of all facilities receive. In addition, Ocean Hills was ...
Breaking Medicine News(10 mins):Health News:24/7 Care At Home Welcomes Michael Demoratz, PhD, LCSW, CCM as New Palliative Care Administrator 2Health News:24/7 Care At Home Welcomes Michael Demoratz, PhD, LCSW, CCM as New Palliative Care Administrator 3Health News:The Beryl Institute Opens Applications for 2015 Patient Experience Grant and Scholar Programs 2Health News:The Beryl Institute Opens Applications for 2015 Patient Experience Grant and Scholar Programs 3Health News:Bill to Create Patient Registry for Deadly Cancer Introduced in Congress 2Health News:Boston Web Marketing Attends Google Partners All-Stars Summit 2Health News:Ocean Hills Recovery Receives Accreditation from CARF International 2
... new study shows that getting primary care physicians and ... an excellent way to extend the communication between doctors ... Medical School in London tested the "virtual outreach" method ... at an urban and rural health care facility. About ...
... a new research there has been a finding that, each ... diagnosed in the United States. Nearly 2,000 of these cases ... into a person's diet may reduce their risk of mouth ... cancers worldwide. Researchers have long known tobacco smoking and alcohol ...
... have successfully transplanted cultured stem cells from the healthy ... people who nearly lost their sight in accidents.Sustaining the ... who suffered from conditions such as chemical burns, allergic ... the part of the eye called limbus, were successfully ...
... exposed mainly to sign language use their hands to ... precursor to learning a language. , Dr. Laura-Ann Petitto, ... Sciences and Education at Dartmouth College// in Hanover, New ... lets them unlock the secret of their language.Conventional wisdom ...
... shows the anti-inflammatory drug naproxen may protect people ... drug (NSAID) commonly prescribed for the management of ... the effects of naproxen versus other NSAIDs //in ... heart attacks, in older patients. The study evaluated ...
... report they have successfully used gene therapy to restore ... blindness. A team of scientists led by Jean Bennett, ... this month's Nature Genetics.Their experiment involved dogs with Leber ... affects human infants and for which there is no ...
Cached Medicine News:
Inquire...
Inquire...
... Software is easy to configure for ... balance. Use the standard method or enter ... temperature, pressure, etc.) QualiTrace automatically manages the ... measurements from the balance to the software, ...
Reservoir, High Profile, Multi Well, 12 Row, Pyramid Bottom, 21mL Available Sterile...
Medicine Products: